- Report
- March 2024
- 266 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- March 2024
- 124 Pages
Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2024
- 125 Pages
Asia Pacific
From €1365EUR$1,500USD£1,170GBP
- Report
- June 2023
- 118 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2022
- 39 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- September 2024
- 26 Pages
Australia
From €995EUR$1,171USD£883GBP
- Report
- September 2024
- 29 Pages
China, Hong Kong
From €995EUR$1,171USD£883GBP
- Report
- August 2024
- 104 Pages
China
From €1638EUR$1,800USD£1,404GBP
- Report
- April 2022
- 127 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- October 2024
- 23 Pages
Cameroon
From €995EUR$1,171USD£883GBP
- Report
- August 2024
- 204 Pages
China
From €3640EUR$4,000USD£3,121GBP
The Antitussive market is a subset of the Cough and Cold Drugs market, which is composed of medications used to treat symptoms of the common cold, such as cough, sore throat, and congestion. Antitussives are a type of cough suppressant, which work by reducing the urge to cough and suppressing the reflex that causes coughing. Common ingredients in antitussives include dextromethorphan, codeine, and pholcodine.
Antitussives are available in a variety of forms, including syrups, tablets, capsules, and lozenges. They are available both over-the-counter and by prescription, depending on the active ingredient.
Some companies in the Antitussive market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Show Less Read more